Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

Palatin receives grants for the development of peptide-based therapeutics and diagnostics

Oct. 11, 1996

Geron licenses technologies for use in the treatment of age-related diseases

Oct. 11, 1996

Patent coverage for new gene expression system

Oct. 11, 1996

Patent allowance for SuperGen technology for cancer drug formulation

Oct. 11, 1996

Alkermes' RMP-7 advances through clinical trials

Oct. 11, 1996

First U.S. launch of product using Scherer's Zydis technology

Oct. 11, 1996

Inex and Schering-Plough extend collaboration on gene delivery systems

Oct. 11, 1996

Important milestone reached in Pharmacopeia-Schering-Plough collaboration

Oct. 11, 1996

Dyax grants additional licenses for phage display technology

Oct. 11, 1996

ArQule-Roche Bioscience collaborative agreement

Oct. 11, 1996

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...